複雑性尿路感染症に対するCS-1170の臨床的検討 (CS-1170(CEFMETAZOLE:CMZ)論文特集)
スポンサーリンク
概要
- 論文の詳細を見る
Fifteen patients of complicated urinary tract infection were given CS-1170 at a daily dose of 1.0 g for 5 days, and the following results were obtained.<BR>1) CS-1170 showed the clinical effect as excellent in 3 of 15 cases (20%), good in 6 (40%), the effective cases being 9 (60%).<BR>2) MIC of CS-1170 demonstrated to be more sensitive than that of cefazolin (CEZ).<BR>3) Any noticeable adverse reaction was not observed with CS-1170.
- 公益社団法人 日本化学療法学会の論文
公益社団法人 日本化学療法学会 | 論文
- DISPOSITION OF 7432-8 IN RATS (I)
- CLINICAL STUDIES ON T-1220 IN SURGICAL CASES
- CLINICAL STUDIES OF PIVALOYLOXYMETHYL D-α-AMINOBENZYL-PENICILLINATE HYDROCHLORIDE IN SURGICAL INFECTIONS
- STUDIES ON AC-1370
- Primary treatment with a combination of cyclophosphamide, vincristine, and dacarbazine for recurrent malignant pheochromocytoma: A case report.